This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignee: Nestec S.a.. Active years: 2007-2011.
Location History:
- Epalinges, CH (2007 - 2011)
- Epalinges, FR (2011)
Company Filing History:
Years Active: 2007-2011
Title: Sandra Chennoufi: Innovator in Phage Therapy
Introduction
Sandra Chennoufi is a notable inventor based in Epalinges, Switzerland. She has made significant contributions to the field of phage therapy, particularly in the development of solutions for bacterial diseases. With a total of 3 patents, her work is paving the way for innovative treatments in both human and pet food products.
Latest Patents
One of her latest patents focuses on isolated phages and their use in food or pet food products. This invention relates to phage isolates that exhibit strong lytic activity against pathogenic Enterobacteriaceae. The application of these phages is aimed at treating or preventing bacterial diseases, particularly in pediatric gastroenteritis. The patent also encompasses the preparation of human or pet food products that incorporate these phage isolates.
Career Highlights
Throughout her career, Sandra has worked with prominent companies such as Nestec S.A. and Société des Produits Nestlé S.A. Her experience in these organizations has allowed her to refine her expertise in the application of phage therapy in food products.
Collaborations
Sandra has collaborated with notable professionals in her field, including Harald Bruessow and Josette Sidoti. These partnerships have contributed to her innovative research and development efforts.
Conclusion
Sandra Chennoufi is a pioneering inventor whose work in phage therapy is making a significant impact on the treatment of bacterial diseases. Her contributions are essential in advancing the field and improving health outcomes in both humans and pets.